You haven't searched anything yet.
Company Overview
Rhythm is a global, commercial-stage biopharmaceutical company committed to transforming the care of people living with rare melanocortin-4 receptor (MC4R) pathway diseases. Working at Rhythm means that you are part of a team that’s passionate about transforming the lives of people living with hyperphagia (pathological, insatiable hunger) and severe obesity caused by rare MC4R pathway diseases. We recognize the courage it takes for patients and their caregivers to begin their journey of advocacy to find the answers they need. Their courage inspires us to challenge convention, ask bold questions and seek answers for them. Every day, we strive for excellence through our willingness to adapt, learn, and our tenacity to overcome barriers, together.
Opportunity OverviewAs a member of the Rhythm field-based North America Region team, the Sr. Manager, Field Medical will serve as a trusted scientific partner to the medical/scientific community and will be responsible for establishing, developing, and maintaining relationships with key stakeholders within the geographic area of coverage.This position requires a strong scientific background as the individual will be a credible source of clinical/scientific data to Key Opinion Leaders (KOL), practicing clinicians, professional societies, and payers. They will leverage KOL relationships by identifying collaborative opportunities that align with internal stakeholder strategies. In this role, the individual will also support research initiatives, advisory boards, and other scientific exchange activities to support the Rhythm Medical Affairs medical plan and strategies.This role will be field based, and the current territories include FL, GA, NC, SC, AL and MS. Candidates need to be centrally located, have access to airports, and be available to travel as necessary. Responsibilities and Duties
More about Rhythm
Rhythm is a global, commercial-stage biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of hyperphagia and severe obesity due to rare melanocortin-4 receptor (MC4R) pathway diseases. This is a key biological pathway that regulates weight and hunger. A central element of Rhythm’s mission is to improve the understanding of these diseases and develop management strategies for patients who have no treatment options available to them. Rhythm was founded in 2008 and is based in Boston, MA. The company’s clinical development program is currently focused on several rare MC4R pathway diseases. For healthcare professionals, visit www.RareObesity.com for more information. For those who may be affected or would like to learn more, visit www.LEADforRareObesity.com for more information.
Full Time
Pharmaceutical
$93k-117k (estimate)
02/09/2024
05/06/2024
rhythmtx.com
BOSTON, MA
50 - 100
2008
DAVID MEEKER PRES-CEO
$5M - $10M
Pharmaceutical
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity. The company is leveraging the Rhythm Engine -- comprised of its TEMPO Registry, GO-ID genotyping study and Uncovering Rare Obesity program -- to improve the understanding, diagnosis and potentially the treatment of these disorders. For healthcare professionals, visit www.UNcommonObesity.com for more information. For patients and caregivers, visit www.LEADforRareObesity.com for more information.